Looks like I won the tipping contest!! AWESOME STUFF!!!!! $1+...

Looks like I won the tipping contest!! AWESOME STUFF!!!!! $1+ tomorrow!!!!!!!!!!!!!!!!!!!

http://www.gsk.com/investors/reports/q12009/q12009.pdf

"The strong start to the year of our Japanese business was particularly encouraging, with sales
growth driven by Advair and Relenza. The opportunity for GSK, in the Japanese market is
significant with a substantial schedule of new product launches to come, including newly
received approvals for Allermist and Tykerb."

"Sales of antiviral treatment Relenza were £222 million in the quarter, reflecting significant
orders for pandemic stockpiling from the UK and Japanese Governments."